NDC 72205-075
Deferasorox
Deferasirox
Deferasorox is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Novadoz Pharmaceuticals Llc. The primary component is Deferasirox.
| Product ID | 72205-075_1122f1c0-c160-49db-a31b-90d7521370f5 |
| NDC | 72205-075 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Deferasorox |
| Generic Name | Deferasirox |
| Dosage Form | Granule |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-03-18 |
| Marketing Category | ANDA / |
| Application Number | ANDA214650 |
| Labeler Name | Novadoz Pharmaceuticals LLC |
| Substance Name | DEFERASIROX |
| Active Ingredient Strength | 180 mg/1 |
| Pharm Classes | Iron Chelating Activity [MoA],Iron Chelator [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |